Tag: cocrystal pharma

September 3, 2019

Cocrystal Pharma Presents Positive Preclinical Data for CC-42344

Cocrystal Pharma (NASDAQ:COCP) has announced positive preclinical data of CC-42344 at the ISIRV: Options X for the Control of Influenza...
January 3, 2019

Big Pharma Collaboration Announced with Cocystal and Merck

Cocrystal Pharma and Merck have announced a new partnership that ignited investor attention in early trading on Thursday.
January 3, 2019

Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck

Cocrystal Pharma (NASDAQ:COCP) a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza...
December 2, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arsanis Gains 271 Percent

Arsanis, Tyme Technologies, CohBar, Cocrystal Pharma and Contrafect were last week's top gainers.
November 18, 2018

5 Top Weekly NASDAQ Biotech Stocks: Cocrystal on Top

Cocrystal Pharma, Ra Pharmaceuticals, Avenue Therapeutics, Imprimis Pharmaceuticals and Nightstar Therapeutics were last week's top gainers on the NASDAQ Biotechnology...